Loading clinical trials...
Loading clinical trials...
The aim of this study is to compare the efficacy and safety of empagliflozin, acetazolamide, and metolazone as add-on therapies to loop diuretics in patients with acute decompensated heart failure.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Tanta University
NCT06898515 · Acute Decompensated Heart Failure
NCT07199088 · Acute Decompensated Heart Failure, Heart Failure, Diastolic, and more
NCT06161987 · Acute Decompensated Heart Failure
NCT00762008 · Acute Decompensated Heart Failure, Heart Failure
NCT06459115 · Acute Decompensated Heart Failure
Tanta university
Tanta
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions